dalteparin has been researched along with Infant, Premature, Diseases in 9 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Infant, Premature, Diseases: Diseases that occur in PREMATURE INFANTS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Drug fever caused by dalteparin-sodium (DS), a low-molecular-weight derivative of heparin, is neither listed in the official drug information and nor published as a case report until today." | 7.83 | Dalteparin-sodium induced drug fever in a neonate. ( Nydert, P; Obaya, S; Wackernagel, D, 2016) |
| "Drug fever caused by dalteparin-sodium (DS), a low-molecular-weight derivative of heparin, is neither listed in the official drug information and nor published as a case report until today." | 3.83 | Dalteparin-sodium induced drug fever in a neonate. ( Nydert, P; Obaya, S; Wackernagel, D, 2016) |
| " Protocols vary from center to center, but there is still no consensus regarding the proper dosage or treatment duration." | 1.42 | The Use of Low-Dose Recombinant Tissue Plasminogen Activator to Treat a Preterm Infant with an Intrauterine Spontaneous Arterial Thromboembolism. ( Caner, İ; Demirelli, Y; Kara, M; Tekgündüz, KŞ, 2015) |
| "Enoxaparin 1 mg/kg intravenously every eight hours was used safely in this preterm infant with suspected thrombosis, suggesting that more than one dosing regimen may be appropriate in this population." | 1.31 | Use of enoxaparin in a preterm infant. ( Dunaway, KK; Gal, P; Ransom, JL, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Demirelli, Y | 1 |
| Tekgündüz, KŞ | 1 |
| Caner, İ | 1 |
| Kara, M | 1 |
| Lulic-Botica, M | 1 |
| Rajpurkar, M | 1 |
| Sabo, C | 1 |
| Tutag-Lehr, V | 1 |
| Natarajan, G | 1 |
| Stief, T | 1 |
| Shin, JH | 1 |
| Kim, GN | 1 |
| Kil, HR | 1 |
| Chang, MY | 1 |
| Streif, W | 1 |
| Goebel, G | 1 |
| Chan, AK | 1 |
| Massicotte, MP | 1 |
| Michaels, LA | 1 |
| Gurian, M | 1 |
| Hegyi, T | 1 |
| Drachtman, RA | 1 |
| Finkelstein, Y | 1 |
| Aloni, D | 1 |
| Kimia, A | 1 |
| Sommer, R | 1 |
| Sirota, L | 1 |
| Dunaway, KK | 1 |
| Gal, P | 1 |
| Ransom, JL | 1 |
| Wackernagel, D | 1 |
| Obaya, S | 1 |
| Nydert, P | 1 |
9 other studies available for dalteparin and Infant, Premature, Diseases
| Article | Year |
|---|---|
The Use of Low-Dose Recombinant Tissue Plasminogen Activator to Treat a Preterm Infant with an Intrauterine Spontaneous Arterial Thromboembolism.
Topics: Arterial Occlusive Diseases; Brachial Artery; Dose-Response Relationship, Drug; Drug Therapy, Combin | 2015 |
Fluctuations of anti-Xa concentrations during maintenance enoxaparin therapy for neonatal thrombosis.
Topics: Dose-Response Relationship, Drug; Drug Monitoring; Enoxaparin; Factor Xa; Factor Xa Inhibitors; Fema | 2012 |
LMWH - action-monitoring for all patients.
Topics: Enoxaparin; Factor Xa; Female; Fibrinolytic Agents; Humans; Infant, Premature, Diseases; Male; Throm | 2012 |
Successful use of low molecular weight heparin in intracardiac thrombus of an extremely low birth weight infant.
Topics: Dose-Response Relationship, Drug; Drug Administration Schedule; Echocardiography; Enoxaparin; Female | 2013 |
Use of low molecular mass heparin (enoxaparin) in newborn infants: a prospective cohort study of 62 patients.
Topics: Anticoagulants; Antithrombin III; Catheters, Indwelling; Cohort Studies; Coronary Disease; Dose-Resp | 2003 |
Low molecular weight heparin in the treatment of venous and arterial thromboses in the premature infant.
Topics: Anticoagulants; Dose-Response Relationship, Drug; Enoxaparin; Hemorrhage; Humans; Infant, Low Birth | 2004 |
Deep venous thrombosis in a preterm newborn of a mother with activated protein C resistance.
Topics: Adult; Blood Coagulation Disorders; Enoxaparin; Female; Humans; Infant, Newborn; Infant, Premature, | 1998 |
Use of enoxaparin in a preterm infant.
Topics: Anticoagulants; Enoxaparin; Humans; Infant, Newborn; Infant, Premature, Diseases; Thrombosis | 2000 |
Dalteparin-sodium induced drug fever in a neonate.
Topics: Anticoagulants; Dalteparin; Fever; Heart Diseases; Humans; Infant, Newborn; Infant, Premature; Infan | 2016 |